Akeso Inc. has announced that Summit Therapeutics Inc. (SMMT), its partner for ivonescimab, has entered into a clinical trial ...

Transaction in Own Shares 24 February, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 24 February 2025 it ...

As the industry moves towards a more integrated and diversified vaccine ecosystem, GeoVax’s MVA-based vaccines should provide a scalable, durable, and globally accessible solution that enhances the ...

The combination of Saipem and Subsea7 (the " Combined Company ”) will be renamed Saipem7, and will have a combined backlog of €43 billion 2, Revenue of approx. €20 billion 3 and EBITDA in excess of €2 ...

The Canadian market ended sharply lower on Friday due to heavy selling in technology, materials and energy sectors. Consumer ...

The UK budget logged a record surplus for the month of January on self-assessed taxes but it remained below the official estimate, ...

The British private sector grew at its slowest pace in two months as services continued to expand while manufacturing sunk to its ...

Reversing most of the gains from the previous two months, the Conference Board released a report on Thursday showing an unexpected ...

The Taiwan stock market has moved lower in two straight sessions, sinking almost 180 points or 0.8 percent along the way. The Taiwan ...

Extending the losses in the previous two sessions, the Japanese market is notably lower on Friday, following the broadly negative ...

EQS-News: GeoVax, Inc. / Key word (s): Financial Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification 19.02.2025 / 15:04 CET/CEST The issuer is solely responsible for the ...

The Australian stock market is slightly higher on Friday after opening in the red, snapping a four-session losing streak, despite the ...